7-Misc: Monsanto has supported fair regulation of biotechnology
- To: "GENET NEWS" <GENETemail@example.com>
- Subject: 7-Misc: Monsanto has supported fair regulation of biotechnology
- From: GENET <firstname.lastname@example.org>
- Date: Tue, 16 Feb 99 20:30:48 -0000
- Content-Type: text/plain; charset="US-ASCII"
- Reply-To: GENET <email@example.com>
- Resent-From: firstname.lastname@example.org
- Resent-Message-ID: <"l0jdeC.A.urD.JKiy2"@bakunix.free.de>
- Resent-Sender: email@example.com
- Sender: firstname.lastname@example.org
MONSANTO HAS SUPPORTED FAIR REGULATION OF BIOTECHNOLOGY
St. Louis Post-Dispatch
The Jan. 8 column by Molly Ivins is an excellent example of Will Rogers'
assessment of profound opinion: "It's not what people don't know that
gets them in trouble; it's all the things they know that ain't so."
During the early 1980s and continuing to 1989, I was chairman of [
Monsanto Co. ] 's Biotechnology Strategy Committee. Monsanto had clearly
identified biotechnology as a major corporate objective. We believed we
had more than the usual scientific and marketing issues to manage. More
important, we recognized that the largest potential stumbling block was
lack of freedom to operate because of a flawed regulatory situation that
Monsanto concluded that we could lose the freedom to operate because of
one or both of two possible situations. The first was that products could
turn out to have an adverse impact on the environment or the public. The
other situation would be a perception that there were adverse effects.
Unless both were addressed, we would not be able to capitalize on our
History had taught us that we could go from no regulation to punitive
regulations in a short time, especially if some problem appeared, either
real or perceived. In the early 1980s, vigorous, aggressive opponents of
biotechnology were creating doomsday scenarios daily. Our approach was to
ask for good, tough, science- based regulations well in advance of
products. This would create a win-win situation. First, it would be the
best way to protect the public and the environment as well as making sure
that the public had the perception that the protection was there. The
second benefit was that it would give industry a predictable regulatory
environment in which to operate.
Congress determined that no new laws or agencies were needed. The three
regulatory agencies did end up with an acceptable regulatory system.
There were the usual frustrations and debates about specifics, but
compared to other regulatory issues and considering the magnitude of the
subject, it was handled better than most.
Another aspect was that of legislative and regulatory actions of the
individual states that affected the biotechnology industry. There was a
flurry of activity at the state level. Bills were introduced and
regulations and agencies were created. If this had continued, there could
have been a patchwork of state regulations that would have caused major
problems for the industry. However, with initiative by the federal
agencies, the state regulatory issues essentially went away.
It is fascinating that Bill Lambrecht, who wrote a Dec. 27 article on
Monsanto, and Ivins both were able to ignore the fact that every
science-based organization, ranging from the National Academy of Science
to the medical profession, has addressed the issue of biotechnology and
has supported the concept of agricultural biotechnology. Moreover, the
regulatory approach being used has been supported by both Democratic and
Republican administrations and Congress for 16 years.
The speculative issues raised by Ivins about "jumping species" is very
similar to the demagoguery of Jeremy Rifkin in the 1980s. If she had
bothered to check, that issue is addressed in the regulatory
requirements. If Ivins and Lambrecht can quote from those who destroy
property and those who cannot provide data to substantiate their claims,
why not quote from the world-renown scientists, as well as those who now
have the possibility of sufficient food because of biotechnology?
The non-scientific barriers that are preventing the benefits of
biotechnology from being brought to bear are deplored by all reputable
people. There have been no mishaps, no cries for new agencies or laws.
There is science-based regulation in place. Do we deserve an "A+"? The
answer is "No." However, I'll claim at least a "B+" rather than the "F"
that Ivins and Lambrecht would give us.
-| Hartmut Meyer
-| The European NGO Network on Genetic Engineering
-| Reinhaeuser Landstr. 51
-| D - 37083 Goettingen
-| phone: #49-551-7700027
-| fax : #49-551-7701672
-| email: email@example.com